Physician profile
Toby A Taylor
NPI 1760406730
$1,337.60
in general payments reported to CMS, 2019-2025
16 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $123 · 2021: $92.48 · 2022: $163 · 2023: $247 · 2024: $99.06 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $268.87 | 2019-2025 | Wegovy |
| Glaxosmithkline, LLC. | $168.18 | 2019-2025 | Shingrix |
| Pfizer INC. | $116.51 | 2019-2025 | |
| Astellas Pharma US INC | $110.47 | 2019-2023 | Veozah |
| Abbvie INC. | $108.33 | 2019-2024 | Botox |
| Abbott Laboratories | $104.57 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Medtronic, INC. | $100.00 | 2022 | |
| Baxter Healthcare | $99.25 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $78.87 | 2019 | |
| Merck Sharp & Dohme LLC | $59.46 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.89 | 2024-2025 | Xifaxan, Trulance |
| Boston Scientific Corporation | $26.22 | 2021 | |
| Gilead Sciences, INC. | $20.49 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.56 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.22 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toby Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.